Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited has provided an update on its ongoing on-market share buy-back, confirming that a total of 3,947,831 ordinary fully paid shares had been repurchased before the previous trading day, with an additional 146,331 shares bought back on the prior day. The daily notification, dated 7 April 2026 and linked to a program first announced in December 2025, signals continued execution of the company’s capital management strategy, which may support earnings per share and indicate management’s confidence in the company’s valuation for investors.
The latest update amends an earlier notice from 2 April 2026 and reiterates that the buy-back applies to NAN’s ordinary fully paid shares listed on the ASX. While specific financial terms of the purchases are not disclosed in the filing, the steady pace of repurchases underscores an active approach to balance sheet optimisation and may influence share liquidity and ownership concentration over the course of the buy-back.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australia-listed medical technology company trading under the ASX code NAN. The company issues ordinary fully paid shares and operates in capital markets where it actively manages its share structure through on-market buy-back programs.
YTD Price Performance: -6.80%
Average Trading Volume: 705,161
Technical Sentiment Signal: Sell
Current Market Cap: A$1.12B
Learn more about NAN stock on TipRanks’ Stock Analysis page.